Research output per year
Research output per year
Personal profile
Headline
PROFESSOR | Neurology
Fingerprint
Dive into the research topics where Aaron Miller is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Evaluation of immunological responses to third COVID-19 vaccine among people treated with sphingosine receptor-1 modulators and anti-CD20 therapy
Katz Sand, I., Gnjatic, S., Krammer, F., Tuballes, K., Carreño, J. M., Satyanarayan, S., Filomena, S., Staker, E., Tcheou, J., Miller, A., Fabian, M., Safi, N., Nichols, J., Patel, J., Krieger, S., Tankou, S., Horng, S., Klineova, S., Beck, E., Merad, M., & 1 others, Feb 2023, In: Multiple Sclerosis and Related Disorders. 70, 104486.Research output: Contribution to journal › Article › peer-review
5 Scopus citations -
Multiple sclerosis progression: time for a new mechanism-driven framework
International Advisory Committee on Clinical Trials in Multiple Sclerosis, Jan 2023, In: The Lancet Neurology. 22, 1, p. 78-88 11 p.Research output: Contribution to journal › Review article › peer-review
29 Scopus citations -
Secondary Progressive Multiple Sclerosis: A Review of Clinical Characteristics, Definition, Prognostic Tools, and Disease-Modifying Therapies
Ziemssen, T., Bhan, V., Chataway, J., Chitnis, T., Campbell Cree, B. A., Havrdova, E. K., Kappos, L., Labauge, P., Miller, A., Nakahara, J., Oreja-Guevara, C., Palace, J., Singer, B., Trojano, M., Patil, A., Rauser, B. & Hach, T., 1 Jan 2023, In: Neurology: Neuroimmunology and NeuroInflammation. 10, 1Research output: Contribution to journal › Review article › peer-review
Open Access -
A Phase 3, double-blind, placebo-controlled efficacy and safety study of ADS-5102 (Amantadine) extended-release capsules in people with multiple sclerosis and walking impairment
Cohen, J. A., Cameron, M. H., Goldman, M. D., Goodman, A. D., Miller, A. E., Rollins, A., Llorens, L., Patni, R., Elfont, R. & Johnson, R., Apr 2022, In: Multiple Sclerosis Journal. 28, 5, p. 817-830 14 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Differential antibody response to COVID-19 vaccines across immunomodulatory therapies for multiple sclerosis
Satyanarayan, S., Safi, N., Sorets, T., Filomena, S., Zhang, Y., Klineova, S., Fabian, M., Horng, S., Tankou, S., Miller, A., Krieger, S., Lublin, F., Sumowski, J. & Katz Sand, I., Jun 2022, In: Multiple Sclerosis and Related Disorders. 62, 103737.Research output: Contribution to journal › Article › peer-review
Open Access8 Scopus citations
Press/Media
-
Key Updates in the Management of Neuromyelitis Optica Spectrum Disorder
4/07/23
1 item of Media coverage
Press/Media
-
Key Updates in the Management of Neuromyelitis Optica Spectrum Disorder
4/07/23
1 item of Media coverage
Press/Media
-
Reports Summarize COVID-19 Study Results from Icahn School of Medicine at Mount Sinai (Evaluation of Immunological Responses To Third Covid-19 Vaccine Among People Treated With Sphingosine Receptor-1 Modulators and Anti-cd20 Therapy)
Miriam Merad, Erin Beck, Aaron Miller, Fred Lublin, Sylvia Klineova, Sacha Gnjatic, Michelle Fabian, Florian Krammer, Stephen C. Krieger, Sam Horng, Stephanie Tankou, Neha Safi & Neha Safi
21/06/23
1 item of Media coverage
Press/Media
-
Overview of Neuromyelitis Optica Spectrum Disorder (NMOSD)
22/03/23
1 item of Media coverage
Press/Media
-
Glatiramer Acetate Depot Injection Shows T1 and T2 Lesion Reduction in Relapsing MS
24/02/23
1 item of Media coverage
Press/Media